Impact of continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea: A meta-analysis

Sleep and Breathing

Volumn 17, Issue 2, 2013, Pages 495-503

  Guo, Yongzhong ^a   Pan, Lei ^a   Ren, Dunqiang ^b   Xie, Xiaomei ^c  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

^c GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

C reactive protein; Continuous positive airway pressure; Meta analysis; Obstructive sleep apnea

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; BODY MASS; CLINICAL EFFECTIVENESS; EFFECT SIZE; HUMAN; MEASUREMENT; META ANALYSIS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBLISHING; RACE DIFFERENCE; SENSITIVITY ANALYSIS; SEX RATIO; SLEEP DISORDERED BREATHING; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

C-REACTIVE PROTEIN; CONTINUOUS POSITIVE AIRWAY PRESSURE; CONTROLLED CLINICAL TRIALS AS TOPIC; FOLLOW-UP STUDIES; HUMANS; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 84878010684     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-012-0722-2     Document Type: Article

References (50)

1. Epstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP, Ramar K, Rogers R, Schwab RJ, Weaver EM, Weinstein MD (2009) Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 5:263-276
2. Yilmaz F, Ozyildirim S, Talay F, Karaaslan K, Gunduz H (2007) Obstructive sleep apnea as a risk factor for cardiovascular diseases. Cardiol J 14:534-537
3. Martinez D, Klein C, Rahmeier L, da Silva RP, Fiori CZ, Cassol CM, Goncalves SC, Bos AJ (2011) Sleep apnea is a stronger predictor for coronary heart disease than traditional risk factors. Sleep Breath. doi: 10.1007/s11325-011-0559-0
4. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353:2034-2041
5. Kent BD, Ryan S, McNicholas WT (2011) Obstructive sleep apnea and inflammation: relationship to cardiovascular co-morbidity. Respir Physiol Neurobiol 178:475-481
6. Firat Guven S, Turkkani MH, Ciftci B, Ulukavak Ciftci T, Erdogan Y (2012) The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea. Sleep Breath 16:217-221
7. Lee LA, Chen NH, Huang CG, Lin SW, Fang TJ, Li HY (2010) Patients with severe obstructive sleep apnea syndrome and elevated high-sensitivity C-reactive protein need priority treatment. Otolaryngol Head Neck Surg 143:72-77
8. Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, Somers VK (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105:2462-2464
9. Bhushan B, Guleria R, Misra A, Pandey RM, Luthra K, Vikram NK (2009) Obstructive sleep apnoea correlates with C-reactive protein in obese Asian Indians. Nutr Metab Cardiovasc Dis 19:184-189
10. Clearfield MB (2005) C-reactive protein: a new risk assessment tool for cardiovascular disease. J Am Osteopath Assoc 105:409-416
11. Chin K, Nakamura T, Shimizu K, Mishima M, Miyasaka M, Ohi M (2000) Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 109:562-567
12. Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R (2008) Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 134:686-692
13. Takahashi K, Chin K, Nakamura H, Morita S, Sumi K, Oga T, Matsumoto H, Niimi A, Fukuhara S, Yodoi J, Mishima M (2008) Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure. Antioxid Redox Signal 10:715-726
14. Iesato K, Tatsumi K, Saibara T, Nakamura A, Terada J, Tada Y, Sakao S, Tanabe N, Takiguchi Y, Kuriyama T (2007) Decreased lipoprotein lipase in obstructive sleep apnea syndrome. Circ J 71:1293-1298
15. Patruno V, Aiolfi S, Costantino G, Murgia R, Selmi C, Malliani A, Montano N (2007) Fixed and autoadjusting continuous positive airway pressure treatments are not similar in reducing cardiovascular risk factors in patients with obstructive sleep apnea. Chest 131:1393-1399
16. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF (2007) Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176:706-712
17. Steiropoulos P, Tsara V, Nena E, Fitili C, Kataropoulou M, Froudarakis M, Christaki P, Bouros D (2007) Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest 132:843-851
18. Sanchez A, Schwartz AR, Sanchez PL, Fernandez JL, Ramos J, Martin-Herrero F, Gonzalez-Celador R, Ruano R, Bregon I, Martin-Luengo C, Gomez FP (2008) Hemodynamic and inflammatory markers of sleep apnea-hypopnea syndrome and nocturnal hypoxemia: effects of treatment with nasal continuous positive airway pressure. Arch Bronconeumol 44:531-539
19. Carneiro G, Togeiro SM, Ribeiro-Filho FF, Truksinas E, Ribeiro AB, Zanella MT, Tufik S (2009) Continuous positive airway pressure therapy improves hypoadiponectinemia in severe obese men with obstructive sleep apnea without changes in insulin resistance. Metab Syndr Relat Disord 7:537-542
20. Ishida K, Kato M, Kato Y, Yanagihara K, Kinugasa Y, Kotani K, Igawa O, Hisatome I, Shigemasa C, Somers VK (2009) Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea. Chest 136:125-129
21. Nena E, Steiropoulos P, Tzouvelekis A, Tsara V, Hatzizisi O, Kyriazis G, Froudarakis M, Trakada G, Papanas N, Bouros D (2010) Reduction of serum retinol-binding protein-4 levels in nondiabetic obstructive sleep apnea patients under continuous positive airway pressure treatment. Respiration 80:517-523
22. Schiza SE, Mermigkis C, Panagiotis P, Bouloukaki I, Kallergis E, Tzanakis N, Tzortzaki E, Vlachaki E, Siafakas NM (2010) C-reactive protein evolution in obstructive sleep apnoea patients under CPAP therapy. Eur J Clin Invest 40:968-975
23. Mermigkis C, Bouloukaki I, Mermigkis D, Kallergis E, Mavroudi E, Varouchakis G, Tzortzaki E, Siafakas N, Schiza SE (2011) CRP evolution pattern in CPAP-treated obstructive sleep apnea patients. Does gender play a role? Sleep Breath. doi: 10.1007/s11325-011-0580-3
24. Barcelo A, Barbe F, Llompart E, Mayoralas LR, Ladaria A, Bosch M, Agusti AG (2004) Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea. Am J Med 117:118-121
25. Colish J, Walker JR, Elmayergi N, Almutairi S, Alharbi F, Lytwyn M, Francis A, Bohonis S, Zeglinski M, Kirkpatrick ID, Sharma S, Jassal DS (2012) Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI. Chest 141:674-681
26. Kohler M, Ayers L, Pepperell JC, Packwood KL, Ferry B, Crosthwaite N, Craig S, Siccoli MM, Davies RJ, Stradling JR (2009) Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial. Thorax 64:67-73
27. Minoguchi K, Yokoe T, Tanaka A, Ohta S, Hirano T, Yoshino G, O'Donnell CP, Adachi M (2006) Association between lipid peroxidation and inflammation in obstructive sleep apnoea. Eur Respir J 28:378-385
28. Ryan S, Nolan GM, Hannigan E, Cunningham S, Taylor C, McNicholas WT (2007) Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 62:509-514
29. Wang YN, Yang Y, Luo YQ, Chen LL (2005) Effects of nasal continuous positive airway pressure short-term treatment on C-reactive protein and intercellular adhesion molecule-1 in patients with obstructive sleep apnea-hypopnea syndrome. Zhong Nan Da Xue Xue Bao Yi Xue Ban 30:666-669
30. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T, Adachi M (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107:1129-1134
31. Chung S, Yoon IY, Lee CH, Kim JW (2011) The effects of nasal continuous positive airway pressure on vascular functions and serum cardiovascular risk factors in obstructive sleep apnea syndrome. Sleep Breath 15:71-76
32. Higgins J, Green S (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. Accessed on 1 february 2012
33. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
34. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101
35. Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455-463
36. Liu T, Li G, Li L, Korantzopoulos P (2007) Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 49:1642-1648
37. Rifai N, Tracy RP, Ridker PM (1999) Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 45:2136-2141
38. Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, Redline S, Henry JN, Getsy JE, Dinges DF (1993) Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 147:887-895
39. Gay P, Weaver T, Loube D, Iber C (2006) Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep 29:381-401
40. Bravo Mde L, Serpero LD, Barcelo A, Barbe F, Agusti A, Gozal D (2007) Inflammatory proteins in patients with obstructive sleep apnea with and without daytime sleepiness. Sleep Breath 11:177-185
41. Dixon JB, Dixon ME, Anderson ML, Schachter L, O'Brien PE (2007) Daytime sleepiness in the obese: not as simple as obstructive sleep apnea. Obesity (Silver Spring) 15:2504-2511
42. Guilleminault C, Kirisoglu C, Ohayon MM (2004) C-reactive protein and sleep-disordered breathing. Sleep 27:1507-1511
43. Sharma SK, Mishra HK, Sharma H, Goel A, Sreenivas V, Gulati V, Tahir M (2008) Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi. Sleep Med 9:149-156
44. Zouaoui Boudjeltia K, Van Meerhaeghe A, Doumit S, Guillaume M, Cauchie P, Brohee D, Vanhaeverbeek M, Kerkhofs M (2006) Sleep apnoea-hypopnoea index is an independent predictor of high-sensitivity C-reactive protein elevation. Respiration 73:243-246
45. Lui MM, Lam JC, Mak HK, Xu A, Ooi C, Lam DC, Mak JC, Khong PL, Ip MS (2009) C-reactive protein is associated with obstructive sleep apnea independent of visceral obesity. Chest 135:950-956
46. Svensson M, Venge P, Janson C, Lindberg E (2011) Relationship between sleep-disordered breathing and markers of systemic inflammation in women from the general population. J Sleep Res. doi: 10.1111/j.1365-2869.2011.00946.x
47. Roche F, Gaspoz JM, Pichot V, Picard-Kossovsky M, Maudoux D, Garcin A, Celle S, Sforza E, Barthelemy JC (2009) Association between C-reactive protein and unrecognised sleep-disordered breathing in the elderly. Eur Respir J 33:797-803
48. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499-511
49. Friedman M, Bliznikas D, Vidyasagar R, Woodson BT, Joseph NJ (2006) Reduction of C-reactive protein with surgical treatment of obstructive sleep apnea hypopnea syndrome. Otolaryngol Head Neck Surg 135:900-905
50. Kinoshita H, Shibano A, Sakoda T, Ikeda H, Iranami H, Hatano Y, Enomoto T (2006) Uvulopalatopharyngoplasty decreases levels of C-reactive protein in patients with obstructive sleep apnea syndrome. Am Heart J 152:692.e1-692.e5